Article Information
History
- March 11, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Alish B. Palmos1,2,*,†,
- Vincent Millischer3,4,†,
- David K. Menon5,
- Timothy R. Nicholson2,10,
- Leonie Taams6,
- Benedict Michael8,
- COVID Clinical Neuroscience Study Consortium,
- Christopher Hübel1,2,9,‡ and
- Gerome Breen1,2,‡
- 1Social, Genetic & Developmental Psychiatry Centre, Institute of Psychiatry, Psychology & Neuroscience, King’s College London, UK
- 2UK National Institute for Health Research (NIHR) Biomedical Research Centre for Mental Health, South London and Maudsley Hospital, London, UK
- 3Department of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, Austria
- 4Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden
- 5Division of Anaesthesia, Department of Medicine, University of Cambridge
- 6Centre for Inflammation Biology & Cancer Immunology, Department of Inflammation Biology, School of Immunology & Microbial Sciences, King’s College London, UK
- 8Institute of Infection and Global Health, University of Liverpool, UK
- 9National Centre for Register-based Research, Department of Economics and Business Economics, Aarhus University, Aarhus, Denmark
- 10Institute of Psychiatry, Psychology & Neuroscience, King’s College London, UK
- ↵*Indicates corresponding author (alish.palmos{at}kcl.ac.uk)
Posted March 11, 2021.
Proteome-wide Mendelian randomization identifies causal links between blood proteins and severe COVID-19
